Citi Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)
Go back to Citi Reiterates Buy Rating on Madrigal Pharmaceuticals (MDGL)| (NASDAQ: MDGL) | Delayed: 471.66 +0.34 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $471.32 | 52 Week High | $18.24 | |||
| Open | $467.50 | 52 Week Low | $6.60 | |||
| Day High | $472.87 | P/E | N/A | |||
| Day Low | $460.89 | EPS | $0.00 | |||
| Volume | 53,009 | |||||

